| Name | Title | Contact Details |
|---|
Precision Air is a Trenton, NJ-based company in the Business Services sector.
Suntech 3 Inc is a Altamonte Springs, FL-based company in the Business Services sector.
20|20 is a global leader in online qualitative research. Since our founding in 1986, 20|20 has been dedicated to research excellence. Our qualitative facilities in Nashville, Charlotte and Miami are annually “Top Rated” by our clients in both industry surveys and our own satisfaction surveys. Since 2001, the QualBoard bulletin board research system has been one of the most widely used and innovative research platforms in the world. Today, QualBoard is available in over 20 languages and has been used in over 90 countries. It has expanded to include a wide array of capabilities not available on any other platform. In addition, 20|20 has developed and supports other research platforms that researchers trust around the world.Now, 20|20 trains more researchers in online qualitative than any other organization in the world through our free online webinars. Today, 20|20 is considered one of the most innovative and technologically advanced firms in the industry. Even so, we never forget our roots of service to our clients and dedication to the practice of excellence in research.
Anniston Hma Inc is a Anniston, AL-based company in the Business Services sector.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.